A pioneering study presented today at ESCMID Global 2025 has uncovered the potential of interleukin-6 (IL-6) as a powerful diagnostic biomarker for the early detection of sepsis in high-risk patient groups, including neonates, children and pregnant women. This study is the first to evaluate IL-6’s diagnostic performance in a real-world cohort across all three populations.
Features
Laboratory Microbial Diagnostics: Current and Future Practice
On Thursday 15 May 2025, the BSMT will celebrate its 40th Anniversary Microbiology Conference. Renowned for the quality of its presentations and speakers, the event will once again offer a cutting edge programme not to be missed.
Process mapping, FMEA and FTA: practical approaches to risk assessment
Stephen MacDonald continues his new series on the management of risk in the pathology laboratory environment with a look at three practical approaches, process mapping, failure mode and effects analysis, and fault tree analysis.
Products
Industry-first modular spectral flow cytometry solution
Beckman Coulter Life Sciences has launched a modular spectral flow cytometry system, the CytoFLEX mosaic Spectral Detection Module, which the company says is an industry first.
Una Health introduces QuikRead go Plus
Una Health has launched the QuikRead go Plus, the latest advancement in rapid diagnostic technology from Aidian, promising an upgraded user interface and enhanced connectivity.
Novel measles antibody detection assay
Revvity has announced the launch of EUROIMMUN’s CE-marked Anti-Measles Virus ELISA 2.0 (IgG) to support the diagnosis of a measles virus infection or to determine the immune status against measles virus.
Tecan introduces Veya for scalable digital automation
Tecan has unveiled Veya, its new liquid handling platform designed to bring efficiency, precision and compliance to laboratories of all sizes.
Latest Issues
UK NEQAS IMPROVES PATIENT CARE
We aim to improve patient care through monitoring the quality of tests and their reporting, in an independent manner and on a not-for-profit basis.
We are here to help ensure optimal quality in testing for the benefit of patients.
We believe that the result of tests should be:
BSMT 40th Anniversary Microbiology Conference
RAF Museum, Hendon, London NW9 5LL
15 May, 2025
Transforming Digital Pathology & AI: The Path Forward
Royal College Of Physicians Of Edinburgh
15 May, 2025
The 10 Year Plan - Clinical Innovations Expo
Jubilee Hotel and Conference Centre, Nottingham, UK
15 May, 2025
Incorrect Blood Component Transfused: a SHOT webinar
Online
21 May 2025
Near miss reporting and WBIT: a SHOT webinar
Online
9 June 2025